{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:05:31Z","timestamp":1790744731496,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anemia represents a frequent and clinically burdensome complication in patients with primary lung cancer receiving platinum-based regimens, yet robust risk stratification tools that integrate multidimensional clinical data and undergo external validation remain scarce. This multicenter study sought to develop and externally validate a machine learning-based predictive model for CIA in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 3,434 patients with primary lung cancer were retrospectively enrolled from two geographically distinct institutions, with 3,097 assigned to the training\/internal validation set (7:3 split) and 337 retained as an independent external validation set. Variables with missing rates exceeding 30% were excluded, and remaining missing data were imputed using multiple imputation by chained equations (MICE). Thirteen candidate predictors were preselected via univariate screening and least absolute shrinkage and selection operator (LASSO) regression. Nine machine learning algorithms were developed and comparatively evaluated using area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analysis. Model interpretability was achieved through SHapley Additive exPlanations (SHAP). The primary outcome was defined as hemoglobin levels &amp;lt; 100 g\/L (CTCAE Grade \u2265 2) recorded during the first two cycles of chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the nine candidate models, LightGBM achieved the highest discriminative performance, with AUCs of 0.871 (95% CI: 0.852\u20130.891) in the training set, 0.797 (95% CI: 0.763\u20130.831) in internal validation, and 0.684 (95% CI: 0.626\u20130.742) in the external validation set derived from Linfen Central Hospital. Calibration and decision curve analyses consistently demonstrated superior agreement and net clinical benefit for LightGBM across all three datasets. SHAP-based interpretation identified lymphocyte count, D-dimer, alanine aminotransferase, total bilirubin, sex, and albumin as the six most influential predictors, with D-dimer, female sex, and outpatient admission positively associated with anemia risk, whereas lymphocyte count, liver function indices, and albumin showed inverse associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The LightGBM-based model developed herein demonstrates acceptable and moderate predictive performance, satisfactory calibration, and potential clinical utility across geographically diverse populations, offering a preliminary risk-stratification tool for early identification of lung cancer patients at elevated anemia risk prior to chemotherapy initiation. However, given the modest external validation performance, cautious interpretation and further refinement are warranted before widespread clinical deployment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1948751","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:52:35Z","timestamp":1790743955000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a machine learning-based prediction model for anemia risk in patients with primary lung cancer receiving platinum-based chemotherapy: a multicenter study"],"prefix":"10.3389","volume":"16","author":[{"given":"Kaining","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Oncology, Linfen Central Hospital","place":["Linfen, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Linfen Central Hospital","place":["Linfen, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Records and Statistics, Affiliated Banan Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Linfen Central Hospital","place":["Linfen, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Linfen Central Hospital","place":["Linfen, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Oncology, Linfen Central Hospital","place":["Linfen, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Linfen Central Hospital","place":["Linfen, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jierong","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Oncology, Linfen Central Hospital","place":["Linfen, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Linfen Central Hospital","place":["Linfen, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Linfen Central Hospital","place":["Linfen, Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102693","article-title":"Global burden of lung cancer in 2022 and projections to 2050: Incidence and mortality estimates from GLOBOCAN","volume":"93","author":"Zhou","year":"2024","journal-title":"Cancer Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2025.01.003","article-title":"The epidemiological landscape of lung cancer: current status, temporal trend and future projections based on the latest estimates from GLOBOCAN 2022","volume":"5","author":"Ji","year":"2025","journal-title":"J Natl Cancer Cent"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-2025-584","article-title":"A narrative review of pathologic response in non-small cell lung cancer: challenges, implications, and future directions","volume":"14","author":"Li","year":"2025","journal-title":"Transl Lung Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s501420","article-title":"Genetic navigation: A narrative review of XRCC1 polymorphism impact on platinum-based chemotherapy outcomes in NSCLC patients","volume":"17","author":"Permatasari","year":"2025","journal-title":"Cancer Manag Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7147","article-title":"Analysis of related factors of CRA in lung cancer patients with different serum iron levels: A retrospective cohort study","volume":"13","author":"Li","year":"2024","journal-title":"Cancer Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.06.019","article-title":"The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients","volume":"40","author":"Ludwig","year":"2004","journal-title":"Eur J Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3892\/ol.2025.15377","article-title":"Real-world performance of the machine learning-based prediction of chemotherapy-associated adverse effects in lung cancer","volume":"31","author":"Huang","year":"2025","journal-title":"Oncol Lett"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1362537","article-title":"Efficacy and safety of different immunotherapies combined with chemotherapy as first-line therapy in patients with small cell lung cancer: a network meta-analysis","volume":"15","author":"Gong","year":"2024","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s302722","article-title":"Development and internal validation of a nomogram used to predict chemotherapy-induced neutropenia in non-small cell lung cancer patients: a retrospective cohort study","volume":"13","author":"Zou","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1403392","article-title":"Construction of a risk prediction model for lung infection after chemotherapy in lung cancer patients based on the machine learning algorithm","volume":"14","author":"Sun","year":"2024","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-2025-700","article-title":"Development and validation of a multi-center prognostic model for predicting survival in non-small cell lung cancer using pulmonary and hematological data","volume":"17","author":"Hu","year":"2025","journal-title":"J Thorac Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.06.019","article-title":"Explainable artificial intelligence to identify dosimetric predictors of toxicity in patients with locally advanced non-small cell lung cancer: a secondary analysis of RTOG 0617","volume":"117","author":"Ladbury","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3892\/ol.2024.14350","article-title":"hsa-miR-455-3P as a predictive biomarker of anemia in patients with non-small cell lung cancer treated with carboplatin plus paclitaxel","volume":"27","author":"Vasconcelos","year":"2024","journal-title":"Oncol Lett"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.5124\/jkma.25.0052","article-title":"World medical association declaration of helsinki: ethical principles for medical research involving human participants","volume":"333","year":"2025","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2019.05.021","article-title":"Using the Common Terminology Criteria for Adverse Events (CTCAE \u2013 Version 5.0) to evaluate the severity of adverse events of anticancer therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.329","article-title":"Multiple imputation by chained equations: what is it and how does it work","volume":"20","author":"Azur","year":"2011","journal-title":"Int J Methods Psychiatr Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1684\/ndt.2023.24","article-title":"How to deal with missing data? Multiple imputation by chained equations: recommendations and explanations for clinical practice","volume":"19","author":"Legendre","year":"2023","journal-title":"Nephrol Ther"},{"key":"B19","first-page":"106584","article-title":"Explanation of machine learning models using shapley additive explanation and application for real data in hospital","volume-title":"Comput Methods Programs Biomed","author":"Nohara","year":"2022"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10822-020-00314-0","article-title":"Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions","volume":"34","author":"Rodr\u00edguez-P\u00e9rez","year":"2020","journal-title":"J Comput-Aided Mol Des"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyaf088","article-title":"Estimating and presenting non-linear associations with restricted cubic splines","volume":"54","author":"Discacciati","year":"2025","journal-title":"Int J Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.72020","article-title":"Development of an artificial intelligence web application for predicting chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a prospective study","volume":"15","author":"Zhang","year":"2026","journal-title":"Cancer Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1186\/s12885-025-14387-3","article-title":"Interpretable machine learning model for predicting anastomotic leak after esophageal cancer surgery via LightGBM","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-006-0154-2","article-title":"The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy","volume":"15","author":"Vincent","year":"2007","journal-title":"Support Care Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2023.101058","article-title":"A novel model to predict the risk of hematological toxicity in lung adenocarcinoma patients with pemetrexed plus platinum chemotherapy based on real-world data","volume":"48","author":"Gong","year":"2024","journal-title":"Curr Probl Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00280-021-04239-9","article-title":"Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib\/IIa studies in patients with extensive-stage small cell lung cancer","volume":"87","author":"Li","year":"2021","journal-title":"Cancer Chemother Pharmacol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aam8060","article-title":"Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib","volume":"9","author":"Taylor","year":"2017","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"108103","DOI":"10.1016\/j.lungcan.2025.108103","article-title":"Association of single nucleotide polymorphisms rs7459185 of the HSP\u03b21 gene and the risk of hematological toxicity in lung cancer","volume":"200","author":"Mu\u00f1oz","year":"2025","journal-title":"Lung Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000024695","article-title":"D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report","volume":"100","author":"Matsumoto","year":"2021","journal-title":"Medicine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1542581","article-title":"Prognostic value of postoperative decrease of albumin (\u0394Alb) in combination with GLIM-defined malnutrition for the prediction of postoperative outcomes in rectal cancer patients with normal preoperative albumin levels","volume":"12","author":"Zhou","year":"2025","journal-title":"Front Nutr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092039","article-title":"Uremic toxins affect erythropoiesis during the course of chronic kidney disease: a review","volume":"9","author":"Hamza","year":"2020","journal-title":"Cells"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-022-03298-y","article-title":"Colorectal cancer chemotherapy: can sex-specific disparities impact on drug toxicities","volume":"78","author":"Francia","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.3390\/cancers15194873","article-title":"Blood immune cells as biomarkers in long-term surviving patients with advanced non-small-cell lung cancer undergoing a combined immune\/chemotherapy","volume":"15","author":"M\u00f6ller","year":"2023","journal-title":"Cancers"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1421418","article-title":"Acute toxicity of chemotherapy in central nervous system germ cell tumour patients according to age","volume":"14","author":"Palenzuela","year":"2024","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03392-9","article-title":"Mean platelet volume, thrombocytosis, and survival in non-small cell lung cancer patients treated with first-line pembrolizumab alone or with chemotherapy","volume":"72","author":"Li","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B36","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12911-025-03239-6","article-title":"A prompt framework for enhancing LLM-based explainability of medical machine learning models: an intensive care unit application","volume":"25","author":"Lee","year":"2025","journal-title":"BMC Med Inform Decis Mak"},{"key":"B37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12967-025-07591-z","article-title":"Applications of artificial intelligence in non-small cell lung cancer: from precision diagnosis to personalized prognosis and therapy","volume":"24","author":"Chang","year":"2025","journal-title":"J Transl Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.21203\/rs.3.rs-3035548\/v1","article-title":"Systematic reviews of machine learning in healthcare: a literature review","volume":"24","author":"Kolasa","year":"2023","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12911-024-02830-7","article-title":"External validation of AI-based scoring systems in the ICU: a systematic review and meta-analysis","volume":"25","author":"Rockenschaub","year":"2025","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1948751\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:52:42Z","timestamp":1790743962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1948751\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":39,"alternative-id":["10.3389\/fonc.2026.1948751"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1948751","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"article-number":"1948751"}}